5-FLUOROURACIL METABOLISM MONITORED INVIVO BY F-19 NMR

被引：162

作者：

STEVENS, AN

MORRIS, PG

ILES, RA

SHELDON, PW

GRIFFITHS, JR

机构：

[1] ST GEORGES HOSP,SCH MED,DEPT BIOCHEM,LONDON SW17 0RE,ENGLAND

[2] NATL INST MED RES,MRC,BIOMED NMR CTR,LONDON NW7 1AA,ENGLAND

[3] UNIV LONDON LONDON HOSP,COLL MED,ACAD UNIT METAB & ENDOCRINOL,LONDON E1 1BB,ENGLAND

[4] INST CANC RES,DEPT PHYS,SUTTON SM2 5PX,SURREY,ENGLAND

来源：

关键词：

D O I：

10.1038/bjc.1984.146

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：113 / 117

页数：5

共 17 条

[1] ALGER JR, 1981, SCIENCE, V214, P660, DOI 10.1126/science.7292005
[2] AN UPDATE ON THE BIOCHEMISTRY OF 5-FLUOROURACIL
ARDALAN, B
GLAZER, R
[J]. CANCER TREATMENT REVIEWS, 1981, 8 (03) : 157 - 167
[3] AU JLS, 1982, CANCER RES, V42, P2930
[4] BEDIKIAN AY, 1981, CANCER TREAT REP, V65, P747
[5] CANO JP, 1981, CANCER TREAT REP, V65, P33
[6] CARRICO CK, 1979, CANCER RES, V39, P3694
[7] GADIAN DG, 1982, NMR ITS APPLICATION
[8] METHOTREXATE-INDUCED MISINCORPORATION OF URACIL INTO DNA
GOULIAN, M
BLEILE, B
TSENG, BY
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (04): : 1956 - 1960
[9] GRIFFITHS JR, 1983, LANCET, V1, P1435
[10] HEIDELBERGER C, 1974, HDB EXPTL PHARMACO 2, V38, P193